Dieter Gallemann

Dieter Gallemann is an accomplished professional with extensive experience in drug metabolism and pharmacokinetics (DMPK). Currently serving as Associate Director and Senior DMPK Expert at Nuvisan Pharma Services Group since May 2019, Gallemann also holds a position as Senior Consultant at Nuvisan GmbH since August 2017, focusing on in vitro pharmacokinetics, biotransformation, and drug-drug interaction evaluation. Previous roles include Associate Director and Head of the MetID Lab at both Nuvisan Group and Merck KGaA, where responsibilities encompassed regulatory and late discovery studies on metabolite identification. Gallemann's career began at Ludwig-Maximilians-Universität München, culminating in a PhD in Biochemistry, complemented by a Dipl. Chemist degree in Chemistry from the same institution. His robust background includes leadership positions at Merck Group and Metabion GmbH, underscoring a strong commitment to innovation within the field.